Related Experiment Video
Updated: Jan 5, 2026

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
Published on: October 25, 2024
Immunobiology of Atherosclerosis: A Complex Net of Interactions
Beatriz Herrero-Fernandez1,2, Raquel Gomez-Bris3, Beatriz Somovilla-Crespo4
1LamImSys Lab. Instituto de Investigación Hospital 12 de Octubre (imas12), 28041 Madrid, Spain. beatriz.herrero@uam.es.
Insights
Atherosclerosis, a leading cause of death, involves complex immune responses. Understanding innate and adaptive immunity in this chronic inflammatory disease is key to developing new therapies.
Area of Science:
- Immunology
- Cardiovascular Science
- Pathology
Background:
- Cardiovascular disease is the leading global cause of mortality.
- Atherosclerosis is the primary driver of cardiovascular events, characterized by chronic inflammation.
- Immune system dysregulation significantly contributes to atherosclerosis development and progression.
Purpose of the Study:
- To provide a global perspective on immune responses in atherosclerosis.
- To elucidate the interplay between innate and adaptive immunity in the atherosclerotic microenvironment.
- To highlight the role of immune factors in modulating atherosclerotic lesion progression and stability.
Main Methods:
- Comprehensive review of existing literature on immune pathogenesis in atherosclerosis.
- Analysis of the complex network of interactions between vascular components and immune cells.
- Examination of the balance between proatherogenic and atheroprotective inflammatory responses.
Main Results:
- Atherosclerosis involves endothelial dysfunction, lipid deposition, smooth muscle cell proliferation, and apoptosis.
- Both innate and adaptive immunity play crucial roles in the inflammatory processes of atherosclerosis.
- Interactions among monocytes, macrophages, dendritic cells, T cells, B cells, and foam cells influence lesion stability.
Conclusions:
- Immune responses are central to atherosclerosis pathogenesis.
- Targeting immune pathways offers potential for novel atherosclerosis therapies.
- Further research into immune cell interactions is vital for therapeutic advancements.
Abstract:
Cardiovascular disease is the leading cause of mortality worldwide, and atherosclerosis the principal factor underlying cardiovascular events. Atherosclerosis is a chronic inflammatory disease characterized by endothelial dysfunction, intimal lipid deposition, smooth muscle cell proliferation, cell apoptosis and necrosis, and local and systemic inflammation, involving key contributions to from innate and adaptive immunity. The balance between proatherogenic inflammatory and atheroprotective anti-inflammatory responses is modulated by a complex network of interactions among vascular components and immune cells, including monocytes, macrophages, dendritic cells, and T, B, and foam cells; these interactions modulate the further progression and stability of the atherosclerotic lesion. In this review, we take a global perspective on existing knowledge about the pathogenesis of immune responses in the atherosclerotic microenvironment and the interplay between the major innate and adaptive immune factors in atherosclerosis. Studies such as this are the basis for the development of new therapies against atherosclerosis.
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Inflammation
Coronary Artery Disease II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

